ADAR1 Capital Management »

Bioatla shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Bioatla (BCAB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Bioatla

Tip: Access up to 7 years of quarterly data

All positions including Bioatla held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioatla by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $104k 183k 0.57
2025-06-30 $68k 171k 0.40

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Bioatla

Acorn Capital Advisors
Vanguard Group
Tang Capital Management
Marshall Wace
Acadian Asset Management
Renaissance Technologies
Deutsche Bank Aktiengesellschaft
Geode Capital Management
BlackRock
Millennium Management
Citadel Advisors
Susquehanna International
UBS Group
Jane Street
ADAR1 Capital Management

View all funds holding Bioatla